Increased Survival After Long-Term Treatment With Mibefradil, a Selective T-Channel Calcium Antagonist, in Heart Failure
- 28 February 1997
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 29 (2), 416-421
- https://doi.org/10.1016/s0735-1097(96)00491-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.Hypertension, 1994
- Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarctionAmerican Heart Journal, 1993
- The angiotensin AT2 receptor modulates T‐type calcium current in non‐differentiated NG108‐15 cellsFEBS Letters, 1992
- Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophyThe American Journal of Cardiology, 1992
- The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat heartsCardiovascular Drugs and Therapy, 1990
- Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.Hypertension, 1988
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction).Circulation, 1985
- Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate.Heart, 1983
- Calcium-channel blockers: Pharmacologic considerationsAmerican Heart Journal, 1982